Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein
Science, 2001•science.org
Atherogenic low density lipoproteins are cleared from the circulation by hepatic low density
lipoprotein receptors (LDLR). Two inherited forms of hypercholesterolemia result from loss of
LDLR activity: autosomal dominant familial hypercholesterolemia (FH), caused by mutations
in the LDLR gene, and autosomal recessive hypercholesterolemia (ARH), of unknown
etiology. Here we map the ARH locus to a∼ 1-centimorgan interval on chromosome 1p35
and identify six mutations in a gene encoding a putative adaptor protein (ARH). ARH …
lipoprotein receptors (LDLR). Two inherited forms of hypercholesterolemia result from loss of
LDLR activity: autosomal dominant familial hypercholesterolemia (FH), caused by mutations
in the LDLR gene, and autosomal recessive hypercholesterolemia (ARH), of unknown
etiology. Here we map the ARH locus to a∼ 1-centimorgan interval on chromosome 1p35
and identify six mutations in a gene encoding a putative adaptor protein (ARH). ARH …
Atherogenic low density lipoproteins are cleared from the circulation by hepatic low density lipoprotein receptors (LDLR). Two inherited forms of hypercholesterolemia result from loss of LDLR activity: autosomal dominant familial hypercholesterolemia (FH), caused by mutations in the LDLR gene, and autosomal recessive hypercholesterolemia (ARH), of unknown etiology. Here we map theARH locus to a ∼1-centimorgan interval on chromosome 1p35 and identify six mutations in a gene encoding a putative adaptor protein (ARH). ARH contains a phosphotyrosine binding (PTB) domain, which in other proteins binds NPXY motifs in the cytoplasmic tails of cell-surface receptors, including the LDLR. ARH appears to have a tissue-specific role in LDLR function, as it is required in liver but not in fibroblasts.
AAAS